发明授权
- 专利标题: HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES
- 专利标题(中): 羟基和胆固醇控制组合物和相关的应用
-
申请号: EP03800258.0申请日: 2003-12-23
-
公开(公告)号: EP1597223B1公开(公告)日: 2017-02-22
- 发明人: DASSEUX, Jean-Louis, Henri , ONICIU, Daniela, Carmen
- 申请人: Esperion Therapeutics Inc.
- 申请人地址: 695 KMS Place, 3261 South State Street Ann Arbor, Michigan 48101 US
- 专利权人: Esperion Therapeutics Inc.
- 当前专利权人: Esperion Therapeutics Inc.
- 当前专利权人地址: 695 KMS Place, 3261 South State Street Ann Arbor, Michigan 48101 US
- 代理机构: Schnappauf, Georg
- 优先权: US441795P 20030123
- 国际公布: WO2004067489 20040812
- 主分类号: C07C31/22
- IPC分类号: C07C31/22 ; C07C31/20 ; C07C59/105 ; C07C59/245 ; C07C261/04 ; C07C311/24 ; C07F9/06 ; C07F9/22 ; C07D257/04 ; C07D207/44 ; C07D261/12 ; C07D233/02 ; C07D309/38 ; A61P3/10 ; A61K31/047 ; A61K31/20 ; A61K31/23 ; A61K31/33
摘要:
The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics; such as hypocholesterolemic and hypoglycemic agents.
公开/授权文献
信息查询